Posts by: Santiago Gisler

News

Verona Pharma started a Phase 2b dose-ranging study testing the safety and efficacy of nebulized ensifentrine (RPL554) as an add-on to a standard long-acting bronchodilator in people with moderate to ... Read more

May 17, 2019May 17, 2019

Telehealth Rehabilitation Lowers Hospital Readmissions After COPD Exacerbation, Study Finds

News

Video telehealth rehabilitation reduced the rates that patients with chronic obstructive pulmonary disease (COPD) had to be readmitted within 30 days after they were hospitalized for a pulmonary exacerbation, according ... Read more

April 16, 2019April 16, 2019

FDA Gives Marketing Clearance to Loop Wearable Wristband that Remotely Monitors COPD Patients

News

The Loop wristband device, designed to remotely monitor the condition of patients with chronic diseases such as chronic obstructive pulmonary disease (COPD), received marketing clearance from the U.S. Food ... Read more

March 22, 2019March 22, 2019

New Tool Identifies Support Needs of COPD Patients, Helping to Make Care More Personal and Holistic

News

A new tool identifying broad areas of need by patients receiving palliative or end-of-life care may improve personalized care for patients with advanced chronic obstructive pulmonary disease (COPD) and ... Read more

March 8, 2019March 8, 2019

DNA Differences May Explain COPD Risk in Both Smokers and Non-smokers, Study Says

News

Differences in DNA may explain lung health and the risk of chronic obstructive pulmonary disease (COPD) in both smokers and non-smokers and could help in the future development of preventive ... Read more

February 22, 2019February 22, 2019

COPD Patients Unaware of Their Higher Risk for Lung Cancer, Study Shows

News

Patients with chronic obstructive pulmonary disease (COPD) are unaware of their increased lung cancer risk compared with the general population — attributing their chest symptoms to factors other than potential cancer ... Read more

February 15, 2019February 15, 2019

Statins Linked to Better Outcomes and Improved Lung Function in COPD Patients, Meta-analysis Finds

News

Statins, commonly used to lower blood cholesterol levels, can help chronic obstructive pulmonary disease (COPD) patients by preventing or treating COPD-related comorbidities, and by improving patients’ lung function and exercise ... Read more

February 5, 2019February 5, 2019

Flu Vaccine Reduces Severe Outcomes in COPD Patients, Canadian Study Shows

News

People with chronic obstructive pulmonary disease (COPD) have an increased risk of severe illness, hospitalization, and death if they become infected with the influenza virus, according to a Canadian ... Read more

January 25, 2019January 25, 2019

Ensifentrine Shows Benefit as Add-on Maintenance Therapy in Phase 2 Trial, Verona Pharma Says

News

Data from a three-day Phase 2 clinical trial offered positive results for nebulized ensifentrine (RPL544) as an add-on treatment for chronic obstructive pulmonary disease (COPD), its developer Verona Pharma announced. Ensifentrine is an inhibitor of ... Read more

January 22, 2019January 22, 2019

Cognitive Behavioral Therapy Reduces COPD-related Anxiety and Hospital Visits, Study Shows

News

Cognitive behavioral therapy (CBT) intervention can alleviate anxiety in people with chronic obstructive pulmonary disease (COPD), and reduce long-term hospital costs, a study shows. The results were published in ... Read more

Posts by: Santiago Gisler

Santiago Gisler

Verona Starts Phase 2b Trial to Test Nebulized Ensifentrine as Add-on Therapy

Telehealth Rehabilitation Lowers Hospital Readmissions After COPD Exacerbation, Study Finds

FDA Gives Marketing Clearance to Loop Wearable Wristband that Remotely Monitors COPD Patients

New Tool Identifies Support Needs of COPD Patients, Helping to Make Care More Personal and Holistic

DNA Differences May Explain COPD Risk in Both Smokers and Non-smokers, Study Says

COPD Patients Unaware of Their Higher Risk for Lung Cancer, Study Shows

Statins Linked to Better Outcomes and Improved Lung Function in COPD Patients, Meta-analysis Finds

Flu Vaccine Reduces Severe Outcomes in COPD Patients, Canadian Study Shows

Ensifentrine Shows Benefit as Add-on Maintenance Therapy in Phase 2 Trial, Verona Pharma Says

Cognitive Behavioral Therapy Reduces COPD-related Anxiety and Hospital Visits, Study Shows

Pin It on Pinterest